edgepedia

Medical and health researchers

8,517 articles

Eva Negri

Eva Negri is an Italian cancer epidemiologist, associate professor at the University of Bologna since 2021, who co-leads the annual European cancer mortality prediction papers in Annals of Oncology.

Evan M. Hersh

Evan M. Hersh, also known as Evan Hersh, is a physician-scientist in tumor immunology known for measuring immune competence in cancer patients at M. D. Anderson.

Evan S. Dellon

Evan S. Dellon, also published as Evan Dellon, is an American gastroenterologist at UNC Chapel Hill who directs its Center for Esophageal Diseases and Swallowing and studies eosinophilic esophagitis.

Evan Wood

Evan Wood is a Canadian physician, epidemiologist, and addiction medicine specialist at the University of British Columbia, known for HIV research among injection drug users and as a founding principal investigator of Insite.

Evangelia G. Kranias

Evangelia G. Kranias, known as Litsa Kranias, is a Greek-born cardiovascular scientist at the University of Cincinnati whose research established phospholamban as a central regulator of cardiac contraction.

Evangelos D. Michelakis

Evangelos D. Michelakis is a Greek-born Canadian cardiologist at the University of Alberta who studies pulmonary hypertension, heart failure, and cancer through mitochondrial metabolism, running the first clinical trials of mitochondria-targeting drugs.

Evanthia Galanis

Evanthia Galanis is a Greek-trained neuro-oncologist at Mayo Clinic in Rochester, Minnesota, known for leading the first human testing of oncolytic measles virus against brain tumors.

Evarts Ambrose Graham

Evarts Ambrose Graham was an American surgeon at Washington University in St. Louis who performed the first successful removal of an entire lung for lung cancer in 1933.

Eve Higginbotham

Eve Higginbotham is an American glaucoma specialist and academic administrator who in 1994 became the first woman to head a university-based ophthalmology department in the United States.

Eve Van Cauter

Eve Van Cauter is a Belgian-trained endocrinologist and sleep researcher, Professor Emeritus at the University of Chicago, whose laboratory established insufficient sleep as a metabolic risk factor.

Everett E. Vokes

Everett E. Vokes is an American medical oncologist specializing in lung and head and neck cancer, chair of medicine at the University of Chicago, and president of ASCO in 2021–2022.

Evgeny Cherstvoy

Evgeny Cherstvoy (Евгений Черствый) was a Belarusian pediatric pathologist and medical geneticist at the Minsk Medical Institute, known for the von Voss-Cherstvoy syndrome and Chernobyl thyroid cancer research.

Ewald Weibel

Ewald Weibel (1929–2019) was a Swiss anatomist and cell biologist who pioneered stereology, applied it to the lung, and led the University of Bern's anatomy institute.

Ewan C. Goligher

Ewan C. Goligher, also published as Ewan Goligher, is a Canadian clinician-scientist at the University of Toronto who studies how mechanical ventilation injures the lungs and diaphragm.

Ewan R. Pearson

Ewan R. Pearson is a British physician-scientist, Professor of Diabetic Medicine at the University of Dundee, known for showing that a patient's genetic diagnosis determines which diabetes drug works.

Eyal C. Attar

Eyal C. Attar is a hematologist-oncologist who treated leukemia and myelodysplastic syndromes at Massachusetts General Hospital, then led hematology drug development at Agios and Aprea Therapeutics.

Eyal Gottlieb

Eyal Gottlieb is a cancer metabolism researcher, Vice President for Research at MD Anderson Cancer Center since 2023, known for work on oncometabolites and acetate metabolism in cancer cells.

Ezekiel Emanuel

Ezekiel J. Emanuel, American oncologist and bioethicist, founding chair of NIH's Department of Bioethics (1997–2011), Affordable Care Act drafter, Penn Levy University Professor, brother of Rahm Emanuel, author of "Why I Hope to Die at 75."

Ezra E.W. Cohen

Ezra E.W. Cohen is a Canadian-trained medical oncologist specializing in head and neck cancer, a professor at UC San Diego and Tempus AI's oncology chief medical officer.

F. Anthony Greco

F. Anthony Greco is an American medical oncologist in Nashville known for lung cancer and cancer of unknown primary research, and for co-founding the Sarah Cannon Research Institute.

F. Daniel Foley

F. Daniel Foley (1933–2003) was an American pathologist at the US Army Institute of Surgical Research, known for describing herpesvirus infection in burned patients in 1970.

F. Estelle R. Simons

F. Estelle R. Simons, born Frances Estelle Reed Simons, was a Canadian allergist and clinical immunologist at the University of Manitoba known for research on H1-antihistamines in children and anaphylaxis.

F. Henry Ellis

F. Henry Ellis (1920–2011) was an American thoracic surgeon who helped establish cardiac surgery at the Mayo Clinic and became a leading esophageal authority in Boston.

F. John Gennari

F. John Gennari is an American nephrologist at the University of Vermont known for widely cited New England Journal of Medicine reviews on acid-base and electrolyte disorders.

F. Mason Sones

F. Mason Sones was an American physician at the Cleveland Clinic who performed the first selective coronary arteriogram in 1958, developed cine coronary arteriography, and won the 1983 Lasker Award.

F. Peter Guengerich

F. Peter Guengerich, born 1949, is an American biochemist at Vanderbilt University known for five decades of work on cytochrome P450 enzymes, which metabolize most drugs.

F. Stephen Hodi Jr.

F. Stephen Hodi Jr. is an American medical oncologist who directs the Melanoma Center at Dana-Farber and led the first human trial of ipilimumab, the first approved checkpoint inhibitor for cancer.

Fabien Zoulim

Fabien Zoulim is a French hepatologist and virologist known for hepatitis B cure research, who heads hepatology at the Hospices Civils de Lyon and co-founded ICE-HBV.

Fabio Levi

Fabio Levi, born 1949 in Lausanne, is a Swiss cancer epidemiologist who led the Cancer Epidemiology Unit and the Vaud and Neuchâtel cancer registries at the University of Lausanne.

Fabrice André

Fabrice André, born 1972, is a French medical oncologist specializing in breast cancer, Director of Research at Gustave Roussy since 2020, known for trials of alpelisib and trastuzumab deruxtecan.